299 related articles for article (PubMed ID: 23990207)
21. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
[TBL] [Abstract][Full Text] [Related]
22. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
[TBL] [Abstract][Full Text] [Related]
23. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
24. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
[TBL] [Abstract][Full Text] [Related]
25. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
26. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
27. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
[TBL] [Abstract][Full Text] [Related]
28. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
[TBL] [Abstract][Full Text] [Related]
29. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
[TBL] [Abstract][Full Text] [Related]
30. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
31. Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells.
Zhuge X; Arai H; Xu Y; Murayama T; Kobayashi T; Narumiya S; Kita T; Yokode M
Biochem Biophys Res Commun; 2006 Dec; 351(4):865-71. PubMed ID: 17097058
[TBL] [Abstract][Full Text] [Related]
32. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes.
Davaine JM; Quillard T; Chatelais M; Guilbaud F; Brion R; Guyomarch B; Brennan MÁ; Heymann D; Heymann MF; Gouëffic Y
Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):259-67. PubMed ID: 26652270
[TBL] [Abstract][Full Text] [Related]
33. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
34. Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.
Harper E; Forde H; Davenport C; Rochfort KD; Smith D; Cummins PM
Vascul Pharmacol; 2016 Jul; 82():30-40. PubMed ID: 26924459
[TBL] [Abstract][Full Text] [Related]
35. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
Hofbauer LC; Shui C; Riggs BL; Dunstan CR; Spelsberg TC; O'Brien T; Khosla S
Biochem Biophys Res Commun; 2001 Jan; 280(1):334-9. PubMed ID: 11162519
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.
Tilstam PV; Gijbels MJ; Habbeddine M; Cudejko C; Asare Y; Theelen W; Zhou B; Döring Y; Drechsler M; Pawig L; Simsekyilmaz S; Koenen RR; de Winther MP; Lawrence T; Bernhagen J; Zernecke A; Weber C; Noels H
PLoS One; 2014; 9(2):e87452. PubMed ID: 24498325
[TBL] [Abstract][Full Text] [Related]
37. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo.
Nakagawa Y; Ikeda K; Akakabe Y; Koide M; Uraoka M; Yutaka KT; Kurimoto-Nakano R; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1908-15. PubMed ID: 20651281
[TBL] [Abstract][Full Text] [Related]
38. Role of osteoprotegerin in arterial calcification: development of new animal model.
Orita Y; Yamamoto H; Kohno N; Sugihara M; Honda H; Kawamata S; Mito S; Soe NN; Yoshizumi M
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):2058-64. PubMed ID: 17615383
[TBL] [Abstract][Full Text] [Related]
39. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
40. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution.
van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M
Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
